XML 38 R27.htm IDEA: XBRL DOCUMENT v3.20.2
STOCKHOLDERS' EQUITY (Tables)
6 Months Ended
Jun. 30, 2020
Share-based Payment Arrangement [Abstract]  
Schedule of Composition of Common Stock Capital

a.Common Stock:

Number of shares

Authorized as of

Issued as of

Outstanding as of

June

30, 2020

December

31, 2019

June

30, 2020

December

31, 2019

June

30, 2020

December

31, 2019

Stock of $0.0001 par value:

Common stock

125,000,000

125,000,000

50,075,751

49,081,457

50,075,751

48,898,062

Schedule of Stock Option Activity

A summary of the activity in the stock options granted to employees and members of the board of directors for the six months ended June 30, 2020 and related information are as follows:

Number

of

Options

Weighted

average

exercise

price

Weighted

average

remaining

contractual

term

in years

Aggregate

intrinsic

Value

 

Outstanding as of December 31, 2019

2,112,009

15.44

3.58

168,229

Granted

59,558

101.81

Exercised

(568,165

)

9.84

Outstanding as of June 30, 2020

1,603,402

20.63

3.36

189,447

 

Vested and expected to vest as of June 30, 2020

1,597,973

20.43

5.88

189,113

 

Exercisable as of June 30, 2020

1,314,860

15.45

2.32

162,166

Schedule of RSU Activity

A summary of the activity in the RSUs granted to employees and directors for the six months ended June 30, 2020 is as follows:

Number of

RSUs

Weighted average

grant date

fair value

 

Unvested as of December 31, 2019

2,742,589

52.77

Granted

153,481

88.41

Vested

(547,706

)

41.92

Forfeited

(107,688

)

54.76

Unvested as of June 30, 2020

2,240,676

57.77

Schedule of Recognized Stock-Based Compensation Expense

The Company recognized stock-based compensation expenses related to stock options, RSUs and PSUs granted to employees and non-employee consultants and ESPP in the condensed consolidated statement of income for the three and six months ended June 30, 2020 and 2019, as follows:

Three months ended

June 30,

Six months ended

June 30,

2020

2019

2020

2019

 

Cost of revenues

$

2,359

$

1,651

$

4,632

$

3,005

Research and development

5,847

4,176

11,225

7,666

Selling and marketing

3,445

2,722

6,637

5,126

General and administrative

2,310

2,823

4,240

5,279

 

Total stock-based compensation expense

$

13,961

$

11,372

$

26,734

$

21,076